INSM vs BIIB: Which Stock is Better?
Side-by-side comparison of Insmed Inc and Biogen Inc in 2026
INSM
Insmed Inc
$146.74
BIIB
Biogen Inc
$180.54
Key Metrics Comparison
| Metric | INSM | BIIB | Winner |
|---|---|---|---|
| Market Cap | $31.67B | $26.50B | INSM |
| P/E Ratio | N/A | 20.54 | BIIB |
| EPS (TTM) | $N/A | $8.79 | BIIB |
| Revenue Growth | 1.5% | -0.1% | INSM |
| Gross Margin | 79.7% | 78.9% | INSM |
Analyze INSM
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INSM or BIIB a better investment?
Comparing INSM and BIIB: Insmed Inc has a market cap of $31.67B while Biogen Inc has $26.50B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INSM and BIIB?
INSM (Insmed Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INSM or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INSM or BIIB?
INSM has higher revenue growth at 1.5% vs -0.1% for BIIB.
Which company is more profitable: INSM or BIIB?
Insmed Inc (INSM) has higher gross margins at 79.7% compared to 78.9% for BIIB.
Which is the larger company: INSM or BIIB?
Insmed Inc (INSM) is larger with a market cap of $31.67B compared to $26.50B for BIIB.
Should I buy INSM or BIIB in 2026?
Both INSM and BIIB have investment merit. INSM trades at $146.74 while BIIB trades at $180.54. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INSM and BIIB stock?
Key differences: Market Cap ($31.67B vs $26.50B), P/E Ratio (N/A vs 20.5x), Revenue Growth (1.5% vs -0.1%), Gross Margin (79.7% vs 78.9%).